Paul Sethi, MD
Orthopaedic Surgery · Greenwich, CTNPI 1578536025
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (50.3%), consulting fees and royalties or licence payments — rather than concentrated in one kind of arrangement. Arthrex accounts for 60.9% of it on its own, with 26 other manufacturers making up the rest. Among orthopaedic surgery clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,070 payments — averaging $1364.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$890K
- Shoulder Innovations, Inc.$184K
- Pacira Pharmaceuticals Incorporated$178K
- Zimmer Biomet$92K
- Pacira Therapeutics, Inc.$85K
- Catalyst Orthoscience$10K
- plus $21K from 21 others
Across 28 payments — averaging $6737.21 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Arthrex$189K
Across 7 payments — averaging $1307.51 each. An ownership or investment interest held by the physician or an immediate family member.
- Catalyst Orthoscience$9K
What the payments were for
- Royalty or licence$99,3137%
- Consulting fees$509,36035%
- Speaking & faculty fees$733,75950%
- Travel & lodging$90,7816%
- Food & beverage$24,4662%
- Education$2,3500%
- Gifts$390%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 681 | $889,560 |
| Shoulder Innovations, Inc. | 14 | $184,221 |
| Pacira Pharmaceuticals Incorporated | 101 | $178,166 |
| Zimmer Biomet | 121 | $91,724 |
| Pacira Therapeutics, Inc. | 62 | $85,003 |
| Catalyst Orthoscience | 9 | $10,177 |
| Medical Device Business Services, Inc. | 4 | $8,066 |
| Stryker(2 entities) | 32 | $4,322 |
| Biopoly LLC | 2 | $3,568 |
| Miach Orthopaedics, Inc. | 3 | $894 |
| Smith+Nephew | 8 | $744 |
| Gotham Surgical Solutions & Devices, Inc. | 7 | $737 |
| Coloplast | 5 | $471 |
| Exactech, Inc. | 4 | $454 |
| KCI USA, Inc. | 1 | $400 |
| Medacta USA, Inc. | 4 | $394 |
| Joint Restoration Foundation, Inc. | 1 | $289 |
| Medi-tate Ltd | 1 | $207 |
| Vericel Corporation | 2 | $152 |
| Micromed Inc | 1 | $112 |
| Encore Medical, LP | 1 | $109 |
| Moximed, Inc | 1 | $74 |
| Gemini Mountain Medical, LLC | 1 | $70 |
| Abanza Inc. | 1 | $59 |
| DJO, LLC | 1 | $48 |
| Arcuro Medical Inc | 1 | $33 |
| Aesculap Biologics, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARTHREX$313,513
- InSet System$184,141
- EXPAREL$178,525
- Zilretta$98,882
- Iovera$21,927
- Catalyst Total CSR$5,400
- Archer CSR Total Shoulder System$4,500
- Archer R1 Reverse Shoulder System$4,500
- Juggerknotless Soft Anchor$4,319
- Comprehensive Shoulder System$3,975
- BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION$2,522
- TAPESTRY$2,200
- SHOULDER IMPLANTS SWIVELOCKS KNOTLESS$1,519
- BioPoly Radial Head Implant$1,116
- SHOULDER IMPLANTS SWIVELOCKS PEEK ANCHORS$536
- PREVENA$400
- IOVERA SYSTEM$363
- EQUINOXE$317
- Bioinductive Implant with Arthroscopic Delivery System - Medium$286
- BLUEPRINT PSI SYSTEM$269
How this compares
$1,460,069 in reported general payments places this provider in the 95th percentile of 273 orthopaedic surgery providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 58 | $175 |
| Gabapentin | 26 | $41 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Greenwich
- Michael HeldGreenwich$17K
- Peter WhangNew Haven$1.8M
- James YueShelton$1.3M
- Robert DeveneyDanbury$907K
- James PaceFarmington$721K
- Isaac MossFarmington$676K
- David FrumbergNew Haven$288K
- John KeggiMiddlebury$264K
- Lauren GeaneyFarmington$263K
- Robert StantonFairfield$199K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.